Golub Capital Expands Broadly Syndicated Loan CLO Business to Europe
10.2.2026 15:00:00 CET | Business Wire | Press release
The Firm brings credit-first, top performing platform to meet demand from European partnersIndustry veteran Tyler Wallace appointed to lead strategy in London
Today, Golub Capital (“the Firm”) announced the expansion of its BSL CLO strategy to Europe and the appointment of Tyler Wallace as Managing Director, European Broadly Syndicated Loans. Wallace brings more than 20 years of leading credit experience to the Firm and most recently was a Managing Director and Portfolio Manager of CLOs at Fair Oaks Capital in London.
“This is a natural expansion for us,” said Scott Morrison, Head of BSL at Golub Capital. “The expansion builds on our market-leading U.S. CLO platform and strengthens our ability to deliver comprehensive financing solutions to partners across Europe.”
Said Tyler Wallace, “Golub Capital has an exceptional BSL track record. I am excited to lead this next chapter and bring the Firm’s capabilities to partners in the region.”
As of December 31, 2025, Golub Capital manages over $14 billion in broadly syndicated loans and has completed over 60 BSL CLO transactions since 2007.
Other key business highlights include:
- Closed over $9 billion in financing commitments in Europe since 2020 and set a record with over $3.2 billion in new European commitments in 2025.
- Executed a record $24.4 billion of securitizations in 2025.
- #1 U.S. CLO manager and the #16 U.S. BSL CLO manager based on 2025 issuance.1
- BSL team delivered consistent top quartile performance across most key metrics in each of its last 7 vintages, as measured by Bank of America Research and is rated a Top 5 U.S. BSL CLO Manager, based on data gathered by CLO Research Group Limited.2,3
- The London-based Golub Capital team is now 14-strong, with capabilities across direct lending, structured products and other debt solutions and in core verticals of software, financial services and business services.
About Golub Capital
Golub Capital is a market-leading, award-winning direct lender and experienced private credit manager. We specialize in delivering reliable, creative and compelling financing solutions to companies backed by private equity sponsors. Our sponsor finance expertise also forms the foundation of our Broadly Syndicated Loan and Credit Opportunities investment programs. We nurture long-term, win-win partnerships that inspire repeat business from private equity sponsors and investors.
As of January 1, 2026, Golub Capital had over 1,100 employees and over $90 billion of capital under management, a gross measure of invested capital including leverage. The firm has offices in North America, Europe, Asia and the Middle East. For more information, please visit golubcapital.com.
| _________________________ |
1. Based on 2025 issuance. Source: CLO Global Databank Pitchbook LCD, as of December 31, 2025. |
2. Consistent top quartile performance across most key metrics (BB MVOC, loans > $90, weighted-average price and market value % of target par) in each of the last 7 vintages. Source: Bank of America Research’s “BofA CLO Manager Performance Summary –September 2025 reports,” as of September 30, 2025. Past performance is not indicative of future results. Investments carry the risk of loss. |
3. According to CLO Research Group Limited’s (“CLO Research”) “US BSL CLO Managers: Rankings Based on MVOC (BB) (as of July 18, 2025)," ranked by average percentile of market value over-collateralization (MVOC) at the BB tranche level, based on asset prices as of July 11, 2025. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260210107060/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GenBio AI Builds First World Model of the Human Cell18.8.2026 15:00:00 CEST | Press release
First-of-its-kind system simulates human cell behavior across the full biological hierarchy, from DNA and RNA through protein to the whole-cell level GenBio AI ('GenBio') is an AI for Science company co-founded by Nobel Laureate David Baker, leading AI scientist Eric Xing, and other prominent life science and artificial intelligence researchers from Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute, and other research institutions. Today, the company introduced AIDO Cell, its virtual cell world model — the first system capable of simulating a human cell, both in its natural state and in response to drugs and other interventions, across its full biological hierarchy, from DNA and RNA through protein to the whole-cell level. A Key First in Biological and Medical Sciences: Full-hierarchy virtual cell simulation has been widely identified as a key milestone in computational biology. Compared to the previous efforts by
Xsolla Partner Network Expands Verified Creator Partnerships and Unifies Campaign Management Ahead of gamescom 202618.8.2026 15:00:00 CEST | Press release
Developers Gain Vetted Creator Partnerships And A Single Campaign Workflow, Managed From The Publisher Account They Already Use Xsolla, a global video game commerce company, today announced an expansion of the Xsolla Partner Network ahead of gamescom 2026 in Cologne, giving game developers a simpler, more reliable way to grow their games through creators. The creator platform now lives within Xsolla Publisher Account, where developers already run their business, with verified creator onboarding and a redesigned and unified campaign workflow. Flat-fee campaigns, a new guaranteed payment option alongside revenue share, and data-driven creator recommendations are coming soon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818140062/en/ Graphic: Xsolla Xsolla Partner Network gives developers one place to launch, manage, track, and report on creator campaigns while Xsolla handles payments, payouts, taxes, and compliance.Verifi
KOCCA to Showcase 13 Korean Game Companies at ‘Gamescom 2026’ with PC, Mobile, and VR Lineups18.8.2026 14:48:00 CEST | Press release
- Featuring a diverse lineup of roguelike deckbuilders, AI-powered rhythm education, and cooperative horror games - Ranging from new titles based on the popular animated IP ‘LARVA’ to real-time K-POP dance coaching content - Hands-on experience available August 26–28 at the Korea Joint Pavilion B2B Hall, Koelnmesse, Booth Hall 3.2 C-050g–D051g The Korea Creative Content Agency (KOCCA) announced that 13 Korean game companies will gather under one roof at Gamescom 2026, Europe’s largest game show, held in Cologne, Germany, from August 26 to 28 (B2B, 09:00~20:00). Located in Booth Hall 3.2 C-050g–D051g, the Korea Joint Pavilion offers visitors hands-on experiences with an expansive lineup of titles, ranging from PC and mobile games to VR-powered titles across diverse genres. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818271881/en/ KOCCA will bring 13 Korean game companies to Gamescom 2026 in Cologne, Germany (Image: KOCC
SLB to Support Offshore Production Restoration for Brunei Shell Petroleum18.8.2026 14:06:00 CEST | Press release
Integrated execution model combines multiple disciplines to improve recovery from mature offshore assets Global energy technology company SLB (NYSE: SLB) today announced it has been awarded a contract by Brunei Shell Petroleum (BSP) to support production restoration from shut-in wells across multiple offshore fields. The contract scope spans subsurface evaluation, well candidate selection, engineering and offshore execution. Project management, intervention services, monitoring, metering and marine logistics are integrated within a single coordinated execution model designed to support efficient production restoration. “Building on our long collaboration in the region, this contract reflects a shared commitment to maximizing value from existing offshore resources,” said Gokhan Yarim, senior vice president of Integration, SLB. “Together with BSP, we are combining SLB’s production expertise and integrated execution capabilities to help restore production from shut-in wells, increase reco
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries18.8.2026 12:00:00 CEST | Press release
Renewed collaboration builds on access provided to more than 300 patients with CLL to date and plans to support approximately 1,000 patients through 2028 BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit charitable foundation, and The Max Foundation, a leading global health nonprofit organization, today announced the renewal of their partnership through 2028 to expand access to BRUKINSA® (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively. Building on a collaboration launched in 2023, the renewed partnership reflects the organizations’ shared commitment to improving access to innovative cancer treatments in underserved communities. To date, the partnership has enabled access to BRUKINSA for more than 300 patients with CLL across Armenia, Ethiopia, and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom